NDC 10135-822 – Desvenlafaxine

Desvenlafaxine Succinate 100 mg/1 · Tablet, Extended Release · Oral

Human Prescription Drug

Product NDC10135-822

Product details

Brand name
Desvenlafaxine
Generic name
Desvenlafaxine
Labeler
Marlex Pharmaceuticals, Inc.
Dosage form
Tablet, Extended Release
Route
Oral
Marketing category
ANDA · ANDA204805
Marketed since
July 1, 2025
Listing expires
December 31, 2026
Pharmacologic class
Serotonin and Norepinephrine Reuptake Inhibitor

Active ingredients

Uses, dosage, side effects and warnings for Desvenlafaxine →

Package NDC codes (4)

Package NDCDescriptionSince
10135-822-101000 TABLET, EXTENDED RELEASE in 1 BOTTLE (10135-822-10)Jul 1, 2025
10135-822-1414 TABLET, EXTENDED RELEASE in 1 BOTTLE (10135-822-14)Jul 1, 2025
10135-822-3030 TABLET, EXTENDED RELEASE in 1 BOTTLE (10135-822-30)Jul 1, 2025
10135-822-9090 TABLET, EXTENDED RELEASE in 1 BOTTLE (10135-822-90)Jul 1, 2025

Other Desvenlafaxine products